INTRODUCTION
Currently, coronavirus disease 2019 pandemic caused more than one
million of deaths worldwide, with more than 54 million of confirmed
cases in less than one year. Individuals with malignancies are
considered high risk patients for bacterial, fungal, and viral
infections.
To date a few data are available on the real incidence and outcome of
COVID-19 in patient with chronic lymphocytic leukaemia1,2. An Italian survey involving 33 haematology
centres with at least 100 patients per centres and involving 9930 CLL
patients showed that less than 0.5% (47/9930) were found positive to
COVID-19 3.